

1,402,102 filings since 2004 · latest accepted Nov 4, 2026, 9:38 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Feb 11, 2026 accepted 5:10 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Apr 3, 2025 accepted 8:55 AM ET | ERNAErnexa Therapeutics Inc. | Material agreement |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Mar 24, 2025 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Mar 12, 2025 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Oct 29, 2024 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale5.07Shareholder vote8.01Other events | DocumentSEC ↗ |
Sep 27, 2024 accepted 4:15 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Sep 25, 2024 accepted 4:36 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Dec 20, 2023 accepted 4:20 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Dec 14, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Nov 16, 2023 accepted 4:16 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jul 18, 2023 accepted 8:05 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jul 13, 2023 accepted 6:02 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 2, 2023 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Apr 11, 2023 accepted 7:30 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Feb 22, 2023 accepted 5:29 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Dec 5, 2022 accepted 6:02 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement | DocumentSEC ↗ |
Nov 25, 2022 accepted 6:01 AM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Nov 22, 2022 accepted 4:06 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement1.02Agreement terminated7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 24, 2022 accepted 4:31 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Oct 14, 2022 accepted 4:33 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement | DocumentSEC ↗ |
Sep 15, 2022 accepted 4:30 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement | DocumentSEC ↗ |
Mar 9, 2022 accepted 4:21 PM ET | ERNAErnexa Therapeutics Inc. | 1.01Material agreement3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |